arrow left
arrow right
  • Dan Albasry as Trustee of the Estate of Newal Al Saad, Firas Mohammad v. Barretts Minerals Inc., Beacon Cmp Corp., Brenntag North America Inc. (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Brenntag Specialties Llc (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Charles B. Chrystal Company Inc.;, Colgate Palmolive Co.;, Glaxosmithkline Consumer Healthcare Holdings (Us) Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Glaxosmithkline Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Gsk Consumer Health Inc. (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Lornamead Inc. (Individually And As Successor To Lornamead Acquisitions Ltd. And Lornamead Brands Inc., D/B/A Yardley Of London A/K/A Yardley);, Pfizer Inc., Port Jervis Laboratories Inc. (F/K/A Kolmar Laboratories Inc.);, The Procter & Gamble Co. (Individually, D/B/A, And As Successor To Yardley Of London Ltd., Yardley Of London A/K/A Yardley, Yardley Of London Inc., And Yardley Of London (U.S.) Llc));, Whittaker, Clark & Daniels Inc. (Individually, D/B/A, And Successor To Charles Mathieu Inc. (D/B/A Charles Mathieu & Co. And Chas. Mathieu Inc.), American Talc Company Inc., Metropolitan Talc Company Inc., Imperial Products Co. Inc., And Resource Processo, Yardley Of London Inc. (F/K/A Lentheric Inc. And Lentheric Distributors Inc.);, Yardley Of London Ltd.,, Conopco Inc. (Individually, Doing Business As, And As Successor To Elizabeth Arden Inc. And Evyan Perfumes Inc., Parfums International And Idea Fragrances Co.)Torts - Asbestos document preview
  • Dan Albasry as Trustee of the Estate of Newal Al Saad, Firas Mohammad v. Barretts Minerals Inc., Beacon Cmp Corp., Brenntag North America Inc. (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Brenntag Specialties Llc (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Charles B. Chrystal Company Inc.;, Colgate Palmolive Co.;, Glaxosmithkline Consumer Healthcare Holdings (Us) Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Glaxosmithkline Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Gsk Consumer Health Inc. (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Lornamead Inc. (Individually And As Successor To Lornamead Acquisitions Ltd. And Lornamead Brands Inc., D/B/A Yardley Of London A/K/A Yardley);, Pfizer Inc., Port Jervis Laboratories Inc. (F/K/A Kolmar Laboratories Inc.);, The Procter & Gamble Co. (Individually, D/B/A, And As Successor To Yardley Of London Ltd., Yardley Of London A/K/A Yardley, Yardley Of London Inc., And Yardley Of London (U.S.) Llc));, Whittaker, Clark & Daniels Inc. (Individually, D/B/A, And Successor To Charles Mathieu Inc. (D/B/A Charles Mathieu & Co. And Chas. Mathieu Inc.), American Talc Company Inc., Metropolitan Talc Company Inc., Imperial Products Co. Inc., And Resource Processo, Yardley Of London Inc. (F/K/A Lentheric Inc. And Lentheric Distributors Inc.);, Yardley Of London Ltd.,, Conopco Inc. (Individually, Doing Business As, And As Successor To Elizabeth Arden Inc. And Evyan Perfumes Inc., Parfums International And Idea Fragrances Co.)Torts - Asbestos document preview
  • Dan Albasry as Trustee of the Estate of Newal Al Saad, Firas Mohammad v. Barretts Minerals Inc., Beacon Cmp Corp., Brenntag North America Inc. (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Brenntag Specialties Llc (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Charles B. Chrystal Company Inc.;, Colgate Palmolive Co.;, Glaxosmithkline Consumer Healthcare Holdings (Us) Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Glaxosmithkline Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Gsk Consumer Health Inc. (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Lornamead Inc. (Individually And As Successor To Lornamead Acquisitions Ltd. And Lornamead Brands Inc., D/B/A Yardley Of London A/K/A Yardley);, Pfizer Inc., Port Jervis Laboratories Inc. (F/K/A Kolmar Laboratories Inc.);, The Procter & Gamble Co. (Individually, D/B/A, And As Successor To Yardley Of London Ltd., Yardley Of London A/K/A Yardley, Yardley Of London Inc., And Yardley Of London (U.S.) Llc));, Whittaker, Clark & Daniels Inc. (Individually, D/B/A, And Successor To Charles Mathieu Inc. (D/B/A Charles Mathieu & Co. And Chas. Mathieu Inc.), American Talc Company Inc., Metropolitan Talc Company Inc., Imperial Products Co. Inc., And Resource Processo, Yardley Of London Inc. (F/K/A Lentheric Inc. And Lentheric Distributors Inc.);, Yardley Of London Ltd.,, Conopco Inc. (Individually, Doing Business As, And As Successor To Elizabeth Arden Inc. And Evyan Perfumes Inc., Parfums International And Idea Fragrances Co.)Torts - Asbestos document preview
  • Dan Albasry as Trustee of the Estate of Newal Al Saad, Firas Mohammad v. Barretts Minerals Inc., Beacon Cmp Corp., Brenntag North America Inc. (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Brenntag Specialties Llc (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Charles B. Chrystal Company Inc.;, Colgate Palmolive Co.;, Glaxosmithkline Consumer Healthcare Holdings (Us) Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Glaxosmithkline Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Gsk Consumer Health Inc. (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Lornamead Inc. (Individually And As Successor To Lornamead Acquisitions Ltd. And Lornamead Brands Inc., D/B/A Yardley Of London A/K/A Yardley);, Pfizer Inc., Port Jervis Laboratories Inc. (F/K/A Kolmar Laboratories Inc.);, The Procter & Gamble Co. (Individually, D/B/A, And As Successor To Yardley Of London Ltd., Yardley Of London A/K/A Yardley, Yardley Of London Inc., And Yardley Of London (U.S.) Llc));, Whittaker, Clark & Daniels Inc. (Individually, D/B/A, And Successor To Charles Mathieu Inc. (D/B/A Charles Mathieu & Co. And Chas. Mathieu Inc.), American Talc Company Inc., Metropolitan Talc Company Inc., Imperial Products Co. Inc., And Resource Processo, Yardley Of London Inc. (F/K/A Lentheric Inc. And Lentheric Distributors Inc.);, Yardley Of London Ltd.,, Conopco Inc. (Individually, Doing Business As, And As Successor To Elizabeth Arden Inc. And Evyan Perfumes Inc., Parfums International And Idea Fragrances Co.)Torts - Asbestos document preview
  • Dan Albasry as Trustee of the Estate of Newal Al Saad, Firas Mohammad v. Barretts Minerals Inc., Beacon Cmp Corp., Brenntag North America Inc. (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Brenntag Specialties Llc (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Charles B. Chrystal Company Inc.;, Colgate Palmolive Co.;, Glaxosmithkline Consumer Healthcare Holdings (Us) Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Glaxosmithkline Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Gsk Consumer Health Inc. (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Lornamead Inc. (Individually And As Successor To Lornamead Acquisitions Ltd. And Lornamead Brands Inc., D/B/A Yardley Of London A/K/A Yardley);, Pfizer Inc., Port Jervis Laboratories Inc. (F/K/A Kolmar Laboratories Inc.);, The Procter & Gamble Co. (Individually, D/B/A, And As Successor To Yardley Of London Ltd., Yardley Of London A/K/A Yardley, Yardley Of London Inc., And Yardley Of London (U.S.) Llc));, Whittaker, Clark & Daniels Inc. (Individually, D/B/A, And Successor To Charles Mathieu Inc. (D/B/A Charles Mathieu & Co. And Chas. Mathieu Inc.), American Talc Company Inc., Metropolitan Talc Company Inc., Imperial Products Co. Inc., And Resource Processo, Yardley Of London Inc. (F/K/A Lentheric Inc. And Lentheric Distributors Inc.);, Yardley Of London Ltd.,, Conopco Inc. (Individually, Doing Business As, And As Successor To Elizabeth Arden Inc. And Evyan Perfumes Inc., Parfums International And Idea Fragrances Co.)Torts - Asbestos document preview
  • Dan Albasry as Trustee of the Estate of Newal Al Saad, Firas Mohammad v. Barretts Minerals Inc., Beacon Cmp Corp., Brenntag North America Inc. (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Brenntag Specialties Llc (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Charles B. Chrystal Company Inc.;, Colgate Palmolive Co.;, Glaxosmithkline Consumer Healthcare Holdings (Us) Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Glaxosmithkline Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Gsk Consumer Health Inc. (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Lornamead Inc. (Individually And As Successor To Lornamead Acquisitions Ltd. And Lornamead Brands Inc., D/B/A Yardley Of London A/K/A Yardley);, Pfizer Inc., Port Jervis Laboratories Inc. (F/K/A Kolmar Laboratories Inc.);, The Procter & Gamble Co. (Individually, D/B/A, And As Successor To Yardley Of London Ltd., Yardley Of London A/K/A Yardley, Yardley Of London Inc., And Yardley Of London (U.S.) Llc));, Whittaker, Clark & Daniels Inc. (Individually, D/B/A, And Successor To Charles Mathieu Inc. (D/B/A Charles Mathieu & Co. And Chas. Mathieu Inc.), American Talc Company Inc., Metropolitan Talc Company Inc., Imperial Products Co. Inc., And Resource Processo, Yardley Of London Inc. (F/K/A Lentheric Inc. And Lentheric Distributors Inc.);, Yardley Of London Ltd.,, Conopco Inc. (Individually, Doing Business As, And As Successor To Elizabeth Arden Inc. And Evyan Perfumes Inc., Parfums International And Idea Fragrances Co.)Torts - Asbestos document preview
  • Dan Albasry as Trustee of the Estate of Newal Al Saad, Firas Mohammad v. Barretts Minerals Inc., Beacon Cmp Corp., Brenntag North America Inc. (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Brenntag Specialties Llc (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Charles B. Chrystal Company Inc.;, Colgate Palmolive Co.;, Glaxosmithkline Consumer Healthcare Holdings (Us) Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Glaxosmithkline Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Gsk Consumer Health Inc. (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Lornamead Inc. (Individually And As Successor To Lornamead Acquisitions Ltd. And Lornamead Brands Inc., D/B/A Yardley Of London A/K/A Yardley);, Pfizer Inc., Port Jervis Laboratories Inc. (F/K/A Kolmar Laboratories Inc.);, The Procter & Gamble Co. (Individually, D/B/A, And As Successor To Yardley Of London Ltd., Yardley Of London A/K/A Yardley, Yardley Of London Inc., And Yardley Of London (U.S.) Llc));, Whittaker, Clark & Daniels Inc. (Individually, D/B/A, And Successor To Charles Mathieu Inc. (D/B/A Charles Mathieu & Co. And Chas. Mathieu Inc.), American Talc Company Inc., Metropolitan Talc Company Inc., Imperial Products Co. Inc., And Resource Processo, Yardley Of London Inc. (F/K/A Lentheric Inc. And Lentheric Distributors Inc.);, Yardley Of London Ltd.,, Conopco Inc. (Individually, Doing Business As, And As Successor To Elizabeth Arden Inc. And Evyan Perfumes Inc., Parfums International And Idea Fragrances Co.)Torts - Asbestos document preview
  • Dan Albasry as Trustee of the Estate of Newal Al Saad, Firas Mohammad v. Barretts Minerals Inc., Beacon Cmp Corp., Brenntag North America Inc. (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Brenntag Specialties Llc (Individually And As Successor To Minerals And Pigment Solutions Inc., Successor To Whittaker, Clark & Daniels Inc.);, Charles B. Chrystal Company Inc.;, Colgate Palmolive Co.;, Glaxosmithkline Consumer Healthcare Holdings (Us) Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Glaxosmithkline Llc (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Gsk Consumer Health Inc. (Individually, D/B/A And As Successor To Yardley Of London, Yardley Of London Ltd., Yardley Of London (U.S.) Llc, Smithkline Beecham Plc And Beecham Group Llc);, Lornamead Inc. (Individually And As Successor To Lornamead Acquisitions Ltd. And Lornamead Brands Inc., D/B/A Yardley Of London A/K/A Yardley);, Pfizer Inc., Port Jervis Laboratories Inc. (F/K/A Kolmar Laboratories Inc.);, The Procter & Gamble Co. (Individually, D/B/A, And As Successor To Yardley Of London Ltd., Yardley Of London A/K/A Yardley, Yardley Of London Inc., And Yardley Of London (U.S.) Llc));, Whittaker, Clark & Daniels Inc. (Individually, D/B/A, And Successor To Charles Mathieu Inc. (D/B/A Charles Mathieu & Co. And Chas. Mathieu Inc.), American Talc Company Inc., Metropolitan Talc Company Inc., Imperial Products Co. Inc., And Resource Processo, Yardley Of London Inc. (F/K/A Lentheric Inc. And Lentheric Distributors Inc.);, Yardley Of London Ltd.,, Conopco Inc. (Individually, Doing Business As, And As Successor To Elizabeth Arden Inc. And Evyan Perfumes Inc., Parfums International And Idea Fragrances Co.)Torts - Asbestos document preview
						
                                

Preview

FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Exhibit B FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Date Filed 8/16/2023 3:24 PM Superior Court - Suffolk Docket Number 2384CV01301 4 COMMONWEALTH OF MASSACHUSETTS SUFFOLK, ss. SUPERIOR COURT DEPARTMENT CIVIL ACTION NO.: 23-1301 __________________________________________ F ) KOLMAR LABORATORIES, n/k/a PORT ) JERVIS LABORATORIES, et al. ) kg Plaintiff, ) ) v. ) ) CRISTINA THOMAS, ) Defendant. ) _________________________________________ ) UNOPPOSED MOTION FOR CONTEMPT OF COURT ORDER TO COMPEL PRODUCTION OF ALL PATHOLOGY MATERIALS FROM BRIGHAM AND WOMEN’S HOSPITAL NOW COME the Plaintiff’s, Kolmar Laboratories, n/k/a Port Jervis Laboratories (hereinafter “Port Jervis”), in the above-captioned action, and hereby submit this Motion for Contempt of Court Order to Compel Production of All Pathology Materials from Brigham and Women’s Hospital. As grounds for the Motion, Port Jervis states the following: 1. On or about November 26, 2019, Cristina Thomas (“Ms. Thomas”), Defendant in this Foreign Discovery Matter and Plaintiff in the underlying New York action captioned, Cristina Thomas v. Avon Products, Inc. et al., Supreme Court of the State of New York, In Re: New York City Asbestos Litigation, Index No. 190126/2020 (the “New York Action”), was diagnosed with epithelial mesothelioma. 2. On or about June 4, 2020, Ms. Thomas initiated the New York Action based on her exposure to asbestos-containing products designed, manufactured, supplied, marketed and/or sold by the defendants in the New York Action. 1 FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Date Filed 8/16/2023 3:24 PM Superior Court - Suffolk Docket Number 2384CV01301 3. Ms. Thomas underwent a surgical procedure in 2020 that resulted in portions of pleura and tissue being removed. The procedure was performed at Brigham and Women’s Hospital in Boston. 4. Port Jervis has requested pathology materials from Brigham and Women’s Hospital via a HIPAA authorization so that it can perform a fiber digestion study on them and determine if Ms. Thomas’ mesothelioma is related to an asbestos exposure, and if so if it can be related to the type of asbestos-containing materials which could have been used in its product. 5. Brigham and Women’s Hospital refused access to the material despite the HIPAA-compliant authorization. 6. Port Jervis filed a Motion for Open Commission with the Supreme Court of the State of New York on or about February 22, 2023. The Motion for Open Commission is attached hereto as Exhibit 1.1 7. The Honorable Adam Silvera allowed the Order Directing Open Commission, which is attached hereto as Exhibit 2. 8. On or about June 6, 2023, Port Jervis filed an Application for Discovery Order pursuant to Mass. Gen. Laws c. 233A, § 11 with this Court. 9. On June 8, 2023, this Court Allowed and signed the Discovery Order. The signed Discovery Order is attached herein as Exhibit 3. 10. On or about June 22, 2023, Brigham and Women’s Hospital was successfully served with a Subpoena requesting pathology records. The Affidavit of Service is attached hereto as Exhibit 4. 1 The referenced HIPAA-complaint authorization is included in Exhibit 2. 2 FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Date Filed 8/16/2023 3:24 PM Superior Court - Suffolk Docket Number 2384CV01301 11. Counsel for Port Jervis attempted to contact Brigham and Women’s Hospital on July 21, 2023 and August 11, 2023 to obtain the materials. 12. Brigham and Women’s Hospital informed counsel on those dates that the Subpoena should be served at a different address, even though the facility accepted service of the Subpoena, and would not comply with the Subpoena. 13. Brigham and Women’s Hospital has continuously refused to cooperate to the detriment of the pending New York Action. 14. The New York Action is set for trial on October 3, 2023. 15. The counsel for Plaintiff in the New York Action is not opposing this Motion and to the issuance of the attached Order. WHEREFORE, Port Jervis respectfully requests this Honorable Court to GRANT their Unopposed Motion for Contempt of Court Order to Compel Production of All Original Pathology, and to ORDER Brigham and Women’s Hospital to release all original pathology materials to Port Jervis’s counsel, to the law offices of Clyde & Co US LLP, Attn: Alex Feigenbaum, Esq. at 405 Lexington Avenue, 16th Floor, New York, New York 101742 within fourteen (14) days from receipt of this Order. If Brigham and Women’s Hospital does not comply, Port Jervis further requests sanctions in the form of costs to be issued against Brigham and Women’s Hospital related to the drafting and filing of this instant Motion. 2 Pursuant to the Discovery Order. See Exhibit 3. 3 FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Date Filed 8/16/2023 3:24 PM Superior Court - Suffolk Docket Number 2384CV01301 Respectfully Submitted, CRISTINA THOMAS KOLMAR LABORATORIES, N/K/A By her Attorneys, PORT JERVIS LABORATORIES By Its Attorneys, /s/ Daniel J. Woodard /s/ Mackenzie L. Brockmyre Daniel J. Woodard Mackenzie L. Brockmyre (BBO # 708980) PHILLIPS & PAOLICELLI, LLP mackenzie.brockmyre@clydeco.us 747 Third Ave., 6th Floor Clyde & Co US LLP New York, NY 10022 265 Franklin Street, Suite 701 Tel: (212) 388-5100 Boston, MA 02110 Tel: (617) 728-0050 Dated: August 16, 2023 CERTIFICATE OF SERVICE I, Mackenzie L. Brockmyre, hereby certify that on August 16, 2023, a true and correct copy of the foregoing was served by email upon: Daniel J. Woodward Phillips & Paolicelli, LLP Attorneys for Plaintiff/Defendant 747 third Avenue, 6th Floor New York, New York 10022 /s/ Mackenzie L. Brockmyre Mackenzie L. Brockmyre 4 FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Date Filed 8/16/2023 3:24 PM Superior Court - Suffolk Docket Number 2384CV01301 COMMONWEALTH OF MASSACHUSETTS SUFFOLK, ss. SUPERIOR COURT DEPARTMENT CIVIL ACTION NO.: 23-1301 __________________________________________ ) KOLMAR LABORATORIES, n/k/a PORT ) JERVIS LABORATORIES, et al. ) Plaintiff, ) ) v. ) ) CRISTINA THOMAS, ) Defendant. ) _________________________________________ ) [PROPOSED] ORDER AND NOW, THIS ______ day of ____________, 2023, in consider of the Unopposed Motion for Contempt of Court Order to Compel, it is ORDERED that: 1. The Motion is GRANTED; and 2. Brigham & Women’s Hospital, who provided services for or on behalf of Cristina Thomas (DOB: XX/XX1961, SSN: XXX-XX-5096)1, including any agent or employee thereof, furnish the Plaintiff’s counsel for this Foreign Discovery Matter, Alex Feigenbaum, Esq., Clyde & Co US LLP, 405 Lexington Avenue, 16th Floor, New York, New York 10174, with the following: a. All original pathology materials concerning or related to Cristina Thomas (DOB: XX/XX/1961, SSN: XXX-XX-5096), including but not limited to, tissue slides, paraffin blocks, electron micrographs, wet tissue and frozen tissue, and all immunohistochemical and immunocytochemical stains pertaining to Cristina Thomas. 1 This motion redacts Cristina Thomas’s personal identifying information in accordance with Supreme Judicial Court Rule 1:24. FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Date Filed 8/16/2023 3:24 PM Superior Court - Suffolk Docket Number 2384CV01301 It is hereby FURTHER ORDERED that Brigham and Women’s Hospital, or any employees or agents therefore, deliver the aforementioned materials to Alex Feigenbaum, Esq., Clyde & Co US LLP, 405 Lexington Avenue, 16th Floor, New York, New York 10174, no later than 12:00 p.m. fourteen (14) days from receipt of this order. It is hereby FURTHER ORDERED that sanctions in the form of costs be issued against Brigham and Women’s Hospital relating to the drafting and filing of this instant Motion if the above-referenced materials are not provided by the above-referenced date. A photostatic copy of this order shall have the same force and effect as the original. ENTERED: _____________, 2023 __________________________________ JUSTICE OF THE TRIAL COURT SUPERIOR COURT DEPARTMENT FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Date Filed 8/16/2023 3:24 PM Superior Court - Suffolk Docket Number 2384CV01301 EXHIBIT 1 FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Date Filed 8/16/2023 3:24 PM INDEX NO. 190126/2020 Superior Court - Suffolk Docket NYSCEFNumber 2384CV01301 DOC. NO. 77 RECEIVED NYSCEF: 02/22/2023 SUPREME COURT OF THE STATE OF NEW YORK ALL COUNTIES WITHIN THE CITY OF NEW YORK ---------------------------------------------------------------------x IN RE: NEW YORK CITY ASBESTOS LITIGATION ---------------------------------------------------------------------x CRISTINA THOMAS, NOTICE OF MOTION FOR OPEN COMMISSION Plaintiff, Index No. 190126/2020 -against- Assigned Judge: AVON PRODUCTS, INC., et al., Hon. Adam Silvera, J.S.C. Defendants. -------------------------------------------------------------------x PLEASE TAKE NOTICE that upon the annexed Affirmation of Alex Feigenbaum, dated February 22, 2023, the exhibits annexed thereto, the accompanying Memorandum of Law, and all prior pleadings and proceedings had herein, Defendant Kolmar Laboratories, Inc. n/k/a Port Jervis Laboratories Inc. (“Port Jervis”), will move this Court at the Motion Support Office, located at 60 Centre Street, Room 130, New York, New York 10007, on March 10, 2023, at 9:30 a.m., or as soon thereafter as counsel can be heard, for an Order pursuant to CPLR 3108 and 3111, directing the issuance of an Open Commission to the Court of Common Pleas of the State of Massachusetts, Suffolk County, to issue a subpoena duces tecum to Brigham and Women’s Hospital, Pathology Department, 75 Francis Street, Boston, MA 02115, requiring Brigham & Women’s Hospital to produce pathology materials relating to Plaintiff Cristina Thomas pursuant to a HIPAA authorization, and for such other and further relief as the court may deem just, proper, and equitable. 1 of 2 FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Date Filed 8/16/2023 3:24 PM INDEX NO. 190126/2020 Superior Court - Suffolk Docket NYSCEFNumber 2384CV01301 DOC. NO. 77 RECEIVED NYSCEF: 02/22/2023 PLEASE TAKE FURTHER NOTICE, that pursuant to CPLR § 2214(b), answering papers, if any, are to be served on the undersigned no later than seven days prior to the return date of this motion. Dated: New York, New York February 22, 2023 Yours, etc., CLYDE & CO US LLP By: /s/ Alex Feigenbaum Alex Feigenbaum The Chrysler Building 405 Lexington Avenue, 16th Floor New York, New York 10174 Phone: (212) 710-3900 Fax: (212) 710-3950 Email: alex.feigenbaum@clydeco.us Attorneys for Defendant Port Jervis Laboratories Inc. cc: Phillips & Paolicelli, LLP Attorneys for Plaintiff 747 Third Avenue, 6th Floor New York, New York 10022 2 of 2 FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Date Filed 8/16/2023 3:24 PM INDEX NO. 190126/2020 FILED: NEW YORK COUNTY CLERK 02/22/2023 05:53 PM Superior Court - Suffolk Docket NYSCEFNumber 2384CV01301 DOC. NO. 78 RECEIVED NYSCEF: 02/22/2023 SUPREME COURT OF THE STATE OF NEW YORK ALL COUNTIES WITHIN THE CITY OF NEW YORK ---------------------------------------------------------------------x IN RE: NEW YORK CITY ASBESTOS LITIGATION ---------------------------------------------------------------------x CRISTINA THOMAS, AFFIRMATION IN SUPPORT Plaintiff, Index No. 190126/2020 -against- Assigned Judge: Hon. Adam Silvera, J.S.C. AVON PRODUCTS, INC., et al., Defendants. -------------------------------------------------------------------x ALEX FEIGENBAUM, an attorney duly admitted to practice law before the courts of the State of New York, affirms under the penalties of perjury and says: 1. I am an associate attorney with Clyde & Co US LLP, attorneys for Defendant Kolmar Laboratories, Inc. n/k/a Port Jervis Laboratories Inc. (“Port Jervis”). I am familiar with the facts and circumstances surrounding this matter based on a review of the materials maintained by my office concerning this case. 2. I submit this Affirmation in support of Port Jervis’ motion for an Order, pursuant Suffolk County, to issue a subpoena duces tecum to Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115, requiring Brigham and Women’s Hospital to produce pathology materials relating to Plaintiff Cristina Thomas (“Thomas”) pursuant to a HIPAA authorization, and for such other and further relief as the court may deem just, proper, and equitable. 3. Plaintiff Thomas claims to have developed mesothelioma as a result of exposure to asbestos stemming from her use of talcum powder products. A Summons and Complaint reflecting these claims was filed on May 27, 2020 and thereafter filed an Amended Summons and Complaint 1 of 4 FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Date Filed 8/16/2023 3:24 PM INDEX NO. 190126/2020 FILED: NEW YORK COUNTY CLERK 02/22/2023 05:53 PM Superior Court - Suffolk Docket NYSCEFNumber 2384CV01301 DOC. NO. 78 RECEIVED NYSCEF: 02/22/2023 on June 4, 2020. See Exhibit A. Port Jervis joined issue by serving its Verified Answer on October 8, 2020. See Exhibit B. 4. Thomas underwent a surgical procedure in 2020 that resulted in portions of pleura and tissue being removed. A copy of the pathology report from this procedure is attached hereto as Exhibit C. The procedure was performed at Brigham and Women’s Hospital in Boston. 5. Attached hereto as Exhibit D is a copy of a HIPAA-compliant authorization allowing Port Jervis to obtain Thomas’ medical records (specifically including her pathology materials) from Brigham and Women’s Hospital. 6. Port Jervis has requested pathology materials from this facility via the HIPAA authorization so that it can perform a fiber digestion study on them and determine if Thomas’ mesothelioma is related to asbestos exposure, and if so if it can be related to the type of asbestos- containing materials which could have been used in its product. Brigham and Women’s Hospital has refused to provide these materials despite a HIPAA-compliant authorization allowing for Port Jervis’ access to the materials. 7. Attached hereto for the Court’s reference and consideration are Port Jervis’ draft subpoena duces tecum to be sent via open commission to Brigham and Women’s Hospital (see Exhibit E), and Port Jervis’ proposed order granting an open commission (see Exhibit F). CONCLUSION 8. For the reasons stated herein and in the accompanying Memorandum of Law, Port Jervis requests that this Court issue an Order pursuant to CPLR 3108 and 3111 directing the Superior Court, Suffolk County to issue a subpoena duces tecum to Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115, requiring Brigham and Women’s Hospital to produce pathology materials relating to Plaintiff Cristina Thomas pursuant to a HIPAA 2 of 4 FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Date Filed 8/16/2023 3:24 PM INDEX NO. 190126/2020 FILED: NEW YORK COUNTY CLERK 02/22/2023 05:53 PM Superior Court - Suffolk Docket NYSCEFNumber 2384CV01301 DOC. NO. 78 RECEIVED NYSCEF: 02/22/2023 authorization, and for such other and further relief as the court may deem just, proper, and equitable. Dated: New York, New York February 22, 2023 /s/ Alex Feigenbaum ALEX FEIGENBAUM 3 of 4 FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Date Filed 8/16/2023 3:24 PM INDEX NO. 190126/2020 FILED: NEW YORK COUNTY CLERK 02/22/2023 05:53 PM Superior Court - Suffolk Docket NYSCEFNumber 2384CV01301 DOC. NO. 78 RECEIVED NYSCEF: 02/22/2023 CERTIFICATION Pursuant to 22 NYCRR 130.1-1a, the undersigned, an attorney admitted to practice law before the courts of the State of New York, certifies that, upon information and belief, and after reasonable inquiry, the contentions contained in the within document are not frivolous. Dated: New York, New York February 22, 2023 /s/ Alex Feigenbaum ALEX FEIGENBAUM 4 of 4 FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Date Filed 8/16/2023 3:24 PM INDEX NO. 190126/2020 FILED: NEW YORK COUNTY CLERK 02/22/2023 05:53 PM Superior Court - Suffolk Docket NYSCEFNumber 2384CV01301 DOC. NO. 83 RECEIVED NYSCEF: 02/22/2023 Exhibit E FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Date Filed 8/16/2023 3:24 PM INDEX NO. 190126/2020 FILED: NEW YORK COUNTY CLERK 02/22/2023 05:53 PM Superior Court - Suffolk Docket NYSCEFNumber 2384CV01301 DOC. NO. 83 RECEIVED NYSCEF: 02/22/2023 SUPREME COURT OF THE STATE OF NEW YORK ALL COUNTIES WITHIN THE CITY OF NEW YORK ---------------------------------------------------------------------x IN RE: NEW YORK CITY ASBESTOS LITIGATION ---------------------------------------------------------------------x CRISTINA THOMAS, SUBPOENA DUCES TECUM Plaintiff, Index No. 190126/2020 -against- Assigned Judge: Hon. Adam Silvera, J.S.C. AVON PRODUCTS, INC., et al., Defendants. -------------------------------------------------------------------x THE PEOPLE OF THE STATE OF NEW YORK TO: Brigham and Women’s Hospital Attn: Pathology Department 75 Francis Street Boston, MA 02115 GREETINGS: WE COMMAND YOU, all business and excuses being set aside, to produce and permit inspection of at the time and place indicated herein the following materials identified herein in your possession or control: 1. Pathology Material taken from Plaintiff Cristina Thomas (Date of Birth: 12/05/1961) The responsive items shall be received within twenty-five (25) days of service of this Subpoena Duces Tecum by Alex Feigenbaum, Esq., at Clyde & Co US LLP, 405 Lexington Avenue, 16th Floor, New York, New York 10174, on the 4th day of April, 2023. The circumstances and reasons why the disclosure required by this Subpoena Duces Tecum is sought from you are that you possess material and necessary evidence and/or information pertaining to 1 FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Date Filed 8/16/2023 3:24 PM INDEX NO. 190126/2020 FILED: NEW YORK COUNTY CLERK 02/22/2023 05:53 PM Superior Court - Suffolk Docket NYSCEFNumber 2384CV01301 DOC. NO. 83 RECEIVED NYSCEF: 02/22/2023 the material issues in the above-captioned action pending in the Supreme Court of the State of New York in New York County. THIS IS NOT A DEPOSITION. NO TESTIMONY WILL BE TAKEN. In lieu of a personal appearance, the requested materials may be certified pursuant to N.Y. C.P.L.R § 3122-a, and delivered on or before the scheduled date of production to Alex Feigenbaum, Esq., at Clyde & Co US LLP, 405 Lexington Avenue, 16th Floor, New York, New York 10174. Failure to comply with this Subpoena Duces Tecum is punishable as a contempt of Court and shall make you liable to the persons on whose behalf this Subpoena Duces Tecum was issued for a penalty not to exceed one hundred fifty dollars ($150.00) and all damages sustained by reason of your failure to comply. Please contact Alex Feigenbaum, Esq. at (973) 210-6726 to discuss compliance with this subpoena. Dated: New York, New York February 22, 2023 Yours, etc., CLYDE & CO US LLP By: /s/ Alex Feigenbaum Alex Feigenbaum The Chrysler Building 405 Lexington Avenue, 16th Floor New York, New York 10174 Phone: (212) 710-3900 Fax: (212) 710-3950 Email: alex.feigenbaum@clydeco.us Attorneys for Defendant Port Jervis Laboratories Inc. cc: Phillips & Paolicelli, LLP Attorneys for Plaintiff 747 Third Avenue, 6th Floor New York, New York 10022 2 FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Date Filed 8/16/2023 3:24 PM INDEX NO. 190126/2020 FILED: NEW YORK COUNTY CLERK 02/22/2023 05:53 PM Superior Court - Suffolk Docket NYSCEFNumber 2384CV01301 DOC. NO. 84 RECEIVED NYSCEF: 02/22/2023 Exhibit F FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Date Filed 8/16/2023 3:24 PM INDEX NO. 190126/2020 FILED: NEW YORK COUNTY CLERK 02/22/2023 05:53 PM Superior Court - Suffolk Docket NYSCEFNumber 2384CV01301 DOC. NO. 84 RECEIVED NYSCEF: 02/22/2023 SUPREME COURT OF THE STATE OF NEW YORK ALL COUNTIES WITHIN THE CITY OF NEW YORK ---------------------------------------------------------------------x IN RE: NEW YORK CITY ASBESTOS LITIGATION ---------------------------------------------------------------------x CRISTINA THOMAS, ORDER DIRECTING OPEN COMMISSION Plaintiff, Index No. 190126/2020 -against- Assigned Judge: AVON PRODUCTS, INC., et al., Hon. Adam Silvera, J.S.C. Defendants. -------------------------------------------------------------------x Defendant Kolmar Laboratories, Inc. n/k/a Port Jervis Laboratories Inc. (“Port Jervis”) has moved this Court for an Order directing the issuance of an Open Commission to enable Port Jervis to request that the Superior Court of the State of Massachusetts, Suffolk County issue a subpoena duces tecum to Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115, requiring Brigham and Women’s Hospital to produce pathology materials relating to Plaintiff Cristina Thomas pursuant to a HIPAA authorization, and for such other and further relief as the court may deem just, proper, and equitable. The subpoena duces tecum directs the above-referenced entity to produce Plaintiff’s pathology materials pursuant to a HIPAA authorization to Alex Feigenbaum, Esq., attorney at Clyde & Co US LLP, 405 Lexington Avenue, 16th Floor, New York, New York 10174. The motion, having regularly come on to be heard before this Court on the ____ day of ___________________, 2023, and Port Jervis, having appeared in support thereof through its attorneys, Clyde & Co US, LLP, and Now upon reading all pleadings filed in this matter and due deliberation having been had thereon and upon motion of Clyde and Co. US LLP, attorneys for Port Jervis, it is FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Date Filed 8/16/2023 3:24 PM INDEX NO. 190126/2020 FILED: NEW YORK COUNTY CLERK 02/22/2023 05:53 PM Superior Court - Suffolk Docket NYSCEFNumber 2384CV01301 DOC. NO. 84 RECEIVED NYSCEF: 02/22/2023 ORDERED, that Port Jervis’ Motion for an Open Commission is GRANTED in all respects; and it is further ORDERED that an Open Commission issued to Judges of Superior Court of the State of Massachusetts, Suffolk County, enabling the production of the pathology material demanded in the subpoena; and it is further ORDERED, that Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115, is to produce pathology materials relating to Plaintiff Cristina Thomas pursuant to a HIPAA authorization directly to Alex Feigenbaum, Esq., at Clyde & Co US LLP, 405 Lexington Avenue, 16th Floor, New York, New York 10174, and also ORDERED, that counsel for Port Jervis shall serve a copy of this Order upon all counsel of record within ______ days of receipt thereof. ENTER: __________________________________ Hon. Adam Silvera, J.S.C. FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Date Filed 8/16/2023 3:24 PM INDEX NO. 190126/2020 FILED: NEW YORK COUNTY CLERK 02/22/2023 05:53 PM Superior Court - Suffolk Docket NYSCEFNumber 2384CV01301 DOC. NO. 84 RECEIVED NYSCEF: 02/22/2023 SUPREME COURT OF THE STATE OF NEW YORK ALL COUNTIES WITHIN THE CITY OF NEW YORK ---------------------------------------------------------------------x IN RE: NEW YORK CITY ASBESTOS LITIGATION ---------------------------------------------------------------------x CRISTINA THOMAS, OPEN COMMISSION TO ISSUE SUBPOENA DUCES TECUM Plaintiff, Index No. 190126/2020 -against- Assigned Judge: AVON PRODUCTS, INC., et al., Hon. Adam Silvera, J.S.C. Defendants. -------------------------------------------------------------------x COMMISSION To: Kevin McCaffrey, Esq. Clyde & Co US LLP Chrysler Building 405 Lexington Avenue, 16th Floor New York, New York 10174 OR Any person before whom depositions may be taken under the rules or practice of the State of Massachusetts. We, with full faith in your prudence and competency, have appointed you by a Judge of your Court, Commission and by these present do authorize you to issue a subpoena duces tecum to the below-listed entity, directing it to produce certain documents and things pursuant to Article 31 of the Civil Practice Law and Rules (“CPLR”) of the State of New York, at such time, date, and place as designated in the subpoena duces tecum attached hereto, The entity subject to this Commission is: Brigham and Women’s Hospital Pathology Department 75 Francis Street Boston, MA 02115 FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Date Filed 8/16/2023 3:24 PM INDEX NO. 190126/2020 FILED: NEW YORK COUNTY CLERK 02/22/2023 05:53 PM Superior Court - Suffolk Docket NYSCEFNumber 2384CV01301 DOC. NO. 84 RECEIVED NYSCEF: 02/22/2023 We therefore request of you by the proper and usual process of your Court, to cause this entity to be issued a subpoena duces tecum to produce certain documents and things at such date, time, and place as designated in in the subpoena duces tecum. Pursuant to CPLR 3102(e) of the State of New York: [W]hen under any mandate, writ or commission issued out of any court of record in any other state, territory, district or foreign jurisdiction, or whenever upon notice or agreement, it is required to take the testimony of a witness in the state, he or she may be compelled to appear and testify in the same manner and by the same process as may be employed for the purpose of taking testimony in actions pending in the state. The supreme court or a county court shall make any appropriate order in aid of taking such a deposition. In accordance with the foregoing statute we shall be and stand ready, willing, and able to do the same for you, as we are asking you to do herein, in a similar case when required. WITNESS, the Honorable Adam Silvera, Justice of the Supreme Court of the State of New York, County of New York, this _____day of ___________, 2023. BY THE COURT: _____________________________ FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Date Filed 8/16/2023 3:24 PM INDEX NO. 190126/2020 FILED: NEW YORK COUNTY CLERK 02/22/2023 05:53 PM Superior Court - Suffolk Docket NYSCEFNumber 2384CV01301 DOC. NO. 85 RECEIVED NYSCEF: 02/22/2023 SUPREME COURT OF THE STATE OF NEW YORK ALL COUNTIES WITHIN THE CITY OF NEW YORK ---------------------------------------------------------------------x IN RE: NEW YORK CITY ASBESTOS LITIGATION ---------------------------------------------------------------------x CRISTINA THOMAS, Plaintiff, Index No. 190126/2020 -against- Assigned Judge: Hon. Adam Silvera, J.S.C. AVON PRODUCTS, INC., et al., Defendants. -------------------------------------------------------------------x MEMORANDUM OF LAW OF PORT JERVIS LABORATORIES INC. IN SUPPORT OF MOTION FOR OPEN COMMISSION CLYDE & CO US LLP The Chrysler Building 405 Lexington Avenue, 16th Floor New York, New York 10174 Attorneys for Defendant Port Jervis Laboratories Inc. 1 of 5 FILED: NEW YORK COUNTY CLERK 09/14/2023 03:40 PM INDEX NO. 190002/2023 NYSCEF DOC. NO. 179 RECEIVED NYSCEF: 09/14/2023 Date Filed 8/16/2023 3:24 PM INDEX NO. 190126/2020 FILED: NEW YORK COUNTY CLERK 02/22/2023 05:53 PM Superior Court - Suffolk Docket NYSCEFNumber 2384CV01301 DOC. NO. 85 RECEIVED NYSCEF: 02/22/2023 SUMMARY OF ARGUMENT Defendant Port Jervis Laboratories Inc. (“Port Jervis”) is entitled to an open commission